LH
Income statement / Annual
Last year (2023), Laboratory Corporation of America Holdings's total revenue was $12.16 B,
a decrease of 18.25% from the previous year.
In 2023, Laboratory Corporation of America Holdings's net income was $418.00 M.
See Laboratory Corporation of America Holdings’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$12.16 B
|
$14.88 B
|
$16.12 B
|
$13.98 B
|
$11.55 B
|
$11.33 B
|
$10.44 B
|
$9.64 B
|
$8.68 B
|
$6.01 B
|
| Cost of Revenue |
$9.02 B |
$10.49 B |
$10.50 B |
$9.03 B |
$8.30 B |
$8.16 B |
$6.98 B |
$6.46 B |
$5.78 B |
$3.81 B |
| Gross Profit |
$3.15 B |
$4.39 B |
$5.62 B |
$4.95 B |
$3.25 B |
$3.18 B |
$3.46 B |
$3.18 B |
$2.90 B |
$2.20 B |
| Gross Profit Ratio |
0.26 |
0.29 |
0.35 |
0.35 |
0.28 |
0.28 |
0.33 |
0.33 |
0.33 |
0.37 |
| Research and Development
Expenses |
$2.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$2.02 B
|
$2.00 B
|
$1.95 B
|
$1.73 B
|
$1.62 B
|
$1.57 B
|
$1.81 B
|
$1.63 B
|
$1.62 B
|
$1.20 B
|
| Other Expenses |
$15.50 M |
$259.30 M |
$369.60 M |
$275.40 M |
$243.20 M |
$167.70 M |
-$7.60 M |
$2.60 M |
-$7.80 M |
$10.40 M |
| Operating Expenses |
$2.02 B |
$2.26 B |
$2.32 B |
$2.00 B |
$1.87 B |
$1.80 B |
$2.03 B |
$1.81 B |
$1.79 B |
$1.27 B |
| Cost And Expenses |
$11.04 B |
$12.75 B |
$12.82 B |
$11.03 B |
$10.17 B |
$9.96 B |
$9.01 B |
$8.27 B |
$7.56 B |
$5.08 B |
| Interest Income |
$28.80 M |
$8.90 M |
$10.20 M |
$10.30 M |
$8.80 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$199.60 M |
$180.30 M |
$212.10 M |
$207.40 M |
$240.70 M |
$244.20 M |
$235.10 M |
$219.10 M |
$274.90 M |
$109.50 M |
| Depreciation &
Amortization |
$580.90 M
|
$537.20 M
|
$940.00 M
|
$825.00 M
|
$771.30 M
|
$552.10 M
|
$533.20 M
|
$490.60 M
|
$457.80 M
|
$245.50 M
|
| EBITDA |
$1.70 B
|
$2.74 B
|
$4.12 B
|
$3.54 B
|
$1.97 B
|
$2.11 B
|
$1.97 B
|
$1.88 B
|
$1.58 B
|
$1.20 B
|
| EBITDA Ratio |
0.14 |
0.18 |
0.26 |
0.25 |
0.17 |
0.19 |
0.19 |
0.2 |
0.18 |
0.2 |
| Operating Income Ratio
|
0.09
|
0.12
|
0.2
|
0.17
|
0.12
|
0.12
|
0.13
|
0.14
|
0.12
|
0.15
|
| Total Other
Income/Expenses Net |
-$554.80 M
|
-$191.30 M
|
-$132.90 M
|
-$226.30 M
|
-$225.30 M
|
$138.70 M
|
-$65.10 M
|
-$46.20 M
|
-$109.80 M
|
$8.00 M
|
| Income Before Tax |
$568.90 M |
$1.58 B |
$3.13 B |
$2.22 B |
$1.10 B |
$1.27 B |
$1.13 B |
$1.11 B |
$732.10 M |
$826.70 M |
| Income Before Tax Ratio
|
0.05
|
0.11
|
0.19
|
0.16
|
0.1
|
0.11
|
0.11
|
0.11
|
0.08
|
0.14
|
| Income Tax Expense |
$188.50 M |
$302.00 M |
$747.10 M |
$662.10 M |
$280.00 M |
$384.40 M |
-$139.10 M |
$372.30 M |
$294.10 M |
$314.10 M |
| Net Income |
$418.00 M |
$1.28 B |
$2.38 B |
$1.56 B |
$823.80 M |
$883.70 M |
$1.27 B |
$732.10 M |
$436.90 M |
$511.20 M |
| Net Income Ratio |
0.03 |
0.09 |
0.15 |
0.11 |
0.07 |
0.08 |
0.12 |
0.08 |
0.05 |
0.09 |
| EPS |
4.8 |
14.04 |
24.58 |
15.99 |
8.41 |
8.71 |
12.39 |
7.14 |
4.42 |
6.03 |
| EPS Diluted |
4.77 |
13.96 |
24.38 |
15.88 |
8.36 |
8.61 |
12.21 |
7.02 |
4.34 |
5.91 |
| Weighted Average Shares
Out |
$87.10 M
|
$91.10 M
|
$96.70 M
|
$97.30 M
|
$97.90 M
|
$101.40 M
|
$102.40 M
|
$102.50 M
|
$98.80 M
|
$84.80 M
|
| Weighted Average Shares
Out Diluted |
$87.60 M
|
$91.60 M
|
$97.50 M
|
$98.00 M
|
$98.60 M
|
$102.60 M
|
$103.90 M
|
$104.30 M
|
$100.60 M
|
$86.40 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
